Where is Avlimil located?

Avlimil is headquartered in Cincinnati, United States.

Where does Avlimil rank among its competitors?

Avlimil ranks 20th amongst 39 active competitors, of which 10 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was DOMMA, which secured $1.02M in Feb, 2024.

Who are the top competitors of Avlimil?

Avlimil's top competitors include Gynoveda, Guud and DOMMA. Among them, DOMMA secured the most recent funding round in February, 2024.

Avlimil - 2026 Company Profile, Team & Competitors

Company Details

Natural hormone & menopause symptom relief solutions for women's wellness, offering a range of products designed to alleviate symptoms associated with menopause. The company focuses on providing natural alternatives to support women's health and well-being during this significant life stage. They offer multiple products with options for subscription and cart features for easy online ordering. Customers can create an account and login to manage their purchases. The business model is B2C, directly catering to consumers seeking relief from menopause symptoms. They provide customer support via email and phone. The website includes resources like FAQs, hormone health information, and ingredient details. The company emphasizes natural ingredients and a commitment to helping women live life to the fullest.

Website: officialavlimil.com
Phone Number: +1 **********
Part Of

Key Metrics

Founded Year

2003

Location

Cincinnati, United States

Stage

Unfunded

Ranked

20^th among 39 active competitors

Similar Companies

Gynoveda & 38 more

View Avlimil's full profile

Avlimil has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Avlimil include Gynoveda, Guud and DOMMA. Here is the list of Top 10 competitors of Avlimil, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Gynoveda 2019, Mumbai (India), Series A	Provider of ayurvedic FemTech platform for women	$10.9M	Fireside Ventures, India Alternatives & 8 others	52/100
2nd	Guud 2020, Sint Martens Latem (Belgium), Seed	Developer of nutritional supplements for women health	$2.25M	Kbc, unbundled vc & 9 others	35/100
3rd	DOMMA 2021, Barcelona (Spain), Seed	Developer of supplements and functional foods for women health	$1.02M	Secways, Antai Ventures & 1 others	35/100
4th	Evelyn Health 2022, London (United Kingdom), Unfunded	Provider of nutritional supplemnts to improve women health	-	-	35/100
5th	MidwayBiome 2005, Philadelphia (United States), Seed	Developer of a proprietary daily dietary supplement to enhance bone health in post-menopausal women	$800K	BioAdvance, Rice University	32/100
6th	Spellbound 2023, Noida (India), Unfunded	Provider of a science-backed nutritional supplements for women	-	-	32/100
7th	FEMICYCLE 2023, Delhi (India), Unfunded	Provider of menstrual cups, discs, and related educational resources online	-	-	31/100
8th	Aurelle Health 2024, Hyderabad (India), Unfunded	Provider of supplements formulated for hair, skin, gut, and metabolism	-	-	30/100
9th	Kin 2019, Sydney (Australia), Unfunded	Digital health platform providing reproductive and fertility health solutions to individuals	-	-	29/100
10th	1Balance 2018, San Francisco (United States), Seed	Manufacturer of herbal supplements for menopause support	$2M	Accel	29/100
20th	Avlimil 2003, Cincinnati (United States), Unfunded	Natural hormone & menopause symptom relief solutions for women's wellness	-	-	24/100